Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Global Medical REIT (GMRE-PA) over the last 14 years, with Q3 2025 value amounting to $17.6 million.

  • Global Medical REIT's Free Cash Flow rose 22978.2% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.4 million, marking a year-over-year decrease of 23876.68%. This contributed to the annual value of -$11.6 million for FY2024, which is 11756.23% down from last year.
  • As of Q3 2025, Global Medical REIT's Free Cash Flow stood at $17.6 million, which was up 22978.2% from -$16.4 million recorded in Q2 2025.
  • Global Medical REIT's 5-year Free Cash Flow high stood at $19.4 million for Q2 2024, and its period low was -$54.4 million during Q2 2021.
  • For the 5-year period, Global Medical REIT's Free Cash Flow averaged around -$8.5 million, with its median value being -$9.2 million (2021).
  • As far as peak fluctuations go, Global Medical REIT's Free Cash Flow plummeted by 145748.5% in 2021, and later skyrocketed by 29474.48% in 2022.
  • Global Medical REIT's Free Cash Flow (Quarter) stood at -$9.2 million in 2021, then surged by 294.74% to $18.0 million in 2022, then dropped by 7.59% to $16.6 million in 2023, then crashed by 279.87% to -$29.9 million in 2024, then surged by 158.8% to $17.6 million in 2025.
  • Its last three reported values are $17.6 million in Q3 2025, -$16.4 million for Q2 2025, and -$19.7 million during Q1 2025.